Gene: BNC2
Official Full Name: basonuclin zinc finger protein 2provided by HGNC
Gene Summary: This gene encodes a conserved zinc finger protein. The encoded protein functions in skin color saturation. Mutations in this gene are associated with facial pigmented spots. This gene is also associated with susceptibility to adolescent idiopathic scoliosis. [provided by RefSeq, Jul 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19397 | BNC2 Knockout cell line (HeLa) | Human | BNC2 | 1:3~1:6 | Negative | Online Inquiry |
KO19398 | BNC2 Knockout cell line (HEK293) | Human | BNC2 | 1:3~1:6 | Negative | Online Inquiry |
KO19399 | BNC2 Knockout cell line (A549) | Human | BNC2 | 1:3~1:4 | Negative | Online Inquiry |
BNC2 Gene Knockout Cell Lines are a specialized type of biological product designed to facilitate the study of gene function and regulation by enabling targeted gene disruption. Through the use of CRISPR-Cas9 technology, these cell lines exemplify precise gene editing, where the BNC2 gene is systematically knocked out to elucidate its role in various cellular processes. This tool allows researchers to observe phenotypic changes, gene expression profiles, and interactions involving the BNC2 protein, thus providing critical insights into mechanisms of growth, differentiation, and response to stimuli.
The key function of BNC2 Gene Knockout Cell Lines is their ability to mimic specific genetic alterations seen in disease conditions, making them invaluable in functional genomics. By knocking out BNC2, researchers can investigate its involvement in cancer progression or developmental disorders. The disruption of such genes can trigger compensatory pathways, allowing for in-depth analysis of cellular behavior in culled environments. This mechanism is essential for the discovery of new therapeutic targets and understanding the complexities of gene interactions.
The scientific importance of BNC2 Gene Knockout Cell Lines extends to both research and clinical applications. They are instrumental in drug discovery, biomarker development, and personalized medicine, as they enable researchers to identify genetic vulnerabilities in tumors and assess therapeutic responses. The cell lines facilitate high-throughput screening of small molecules, thus optimizing the drug development process.
What sets BNC2 Gene Knockout Cell Lines apart from alternative methodologies is their unparalleled precision and reliability, which significantly reduce the variability associated with traditional knockout approaches. Moreover, these cell lines provide a reproducible system for downstream assays, enhancing the consistency of experimental results.
For researchers and clinicians seeking to explore gene function and therapeutic potential, BNC2 Gene Knockout Cell Lines represent a cutting-edge solution that streamlines experimental workflows and accelerates discoveries. They stand as a testament to our commitment to providing innovative biological tools that advance research and therapeutic developments. Our expertise in gene editing technologies ensures that our products meet the highest standards, empowering scientists to unravel the complexities of genetic contributions to health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.